Home
About Us
Company Culture
Milestones
Awards and Honors
Social Responsibility
Talent Development
Hot
Recombinant Protein Product
Research and Innovation
R&D Team
R&D Management
Pipelines
Innovation Achievements
Product Category
Drug Products
Peginterferon Alfa-2b Injection
Pegsomatropin Injection
Pegfilgrastim Injection
Molgramostim
Filgrastim
Oprelvekin
API
Reagents
Growth Factors
Interleukins
Interferons
Enzymes
Others
News
Contact Us
English
简体中文
Home
/
News
News and Events
"Pegberon" at the 2017 Xiamen International Fair for Investment & Trade
2017
09-20
Read More
President Xi Jinping's speech at the BRICS Summit inspires Amoytop Biotech to develop international cooperation subject to“BRICS-Plus”.
2017
09-14
Read More
Pegberon" supports CHB standard treatment in the "interferon clinical application
2017
09-01
Read More
Pegylated Interferon, China's First Independent Intellectual Property starts production
2016
11-01
Read More
«
1
...
6
7
8
9
»
Facebook
Twitter
LinkedIn
Instagram
WELCOME
Specialized in R&D and production of recombinant protein drugs, and committed to providing better solutions for viral hepatitis, malignant tumor and immunotherapy etc..
Fax: +86-592-6889110
international@amoytop.com
Tel: +86-592-6889106
Copyright ©
2023
Amoytop Biotech All Rights Reserved. Support by
Leadong
｜
Sitemap
.
Privacy Policy
Email
international@amoytop.com
reagent@amoytop.com
Tel
+86-592-6889106
cell Phone
+86-18060918257
Leave a Message
Get In Touch
Submit
